Document is current
Any future updates will be listed below
-
Authors
Alvarez-Jimenez, Charlems
Antunes, Jacob T.
DeSilvio, Thomas
Wei, Zhouping
Ismail, Marwa
Willis, Joseph E.
Steinhagen, Emily
Purysko, Andrei
Liska, David
Krishnamurthi, Smitha
Crittenden, Marka
Gough, Michael
Young, Kristina
Madabhushi, Anant
Romero, Eduardo
Tiwari, Pallavi
Viswanath, Satish E.
-
Funding
Funding for this research was provided by:
Pharmaceutical Research and Manufacturers of America Foundation (Postdoctoral Fellowship)
Ministerio de Ciencia, Tecnología e Innovación (2019000100060)
National Cancer Institute (1F31CA216935-01A1, 1U01CA248226-01, 1U01CA248226-01)
National Institute of Nursing Research (1R01NR019585-01A1)
National Heart, Lung, and Blood Institute (1R01HL165218-01A1)
National Science Foundation (2320952)
Veterans Affairs Biomedical Laboratory Research and Development Service (1I01BX006439-01)
DOD Peer Reviewed Cancer Research Program (W81XWH-21-1-0725)
Northeast Ohio Renal Research Innovation (Award)
Ohio Third Frontier Technology Validation
JobsOhio Program
- License Information
-
More Information
Article History
Received: 26 February 2025
Accepted: 11 June 2025
First Online: 1 July 2025
Competing interests
: A.M. is an equity holder in Picture Health, Elucid Bioimaging, and Inspirata Inc. Currently, he serves on the advisory board of Picture Health, Aiforia Inc, and SimBioSys. He also currently consults for SimBioSys. He also has sponsored research agreements with AstraZeneca, Boehringer-Ingelheim, Eli-Lilly and Bristol Myers-Squibb. His technology has been licensed to Picture Health and Elucid Bioimaging. He is also involved in three different R01 grants with Inspirata Inc. S.E.V. has received research funding from Pfizer. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
